Veröffentlichungen
Veröffentlichungen
2022
Achajew, A., Brecht, I.B., Radespiel-Tröger, M., Meyer, M., Metzler, M., Bremersdorfer, C., Spix, C., Erdmann, F., Schneider, D.T., & Abele, M.Rare pediatric tumors in Germany – not as rare as expected: a study based on data from the Bavarian Cancer Registry and the German Childhood Cancer Registry.
Voigtländer, S., Hakimhashemi, A., Grundmann, N., Meyer, M., & Müller-Nordhorn, J.
Comparison of trends in early-onset colorectal cancer in North America and Europe
2021
Gennari, P., M. Gerken, J. Meszaros, M. Klinkhammer-Schalke, O. Ortmann, H. Eggemann, and A. Ignatov.
Minimal-Invasive or Open Approach for Surgery of Early Cervical Cancer: The Treatment Center Matters.
Gödde, K., Siegerink, B., Fügemann, H., Keune, D., Sander, S., Schneider, A., Müller-Nordhorn, J., Holmberg, C., Rieckmann, N., Frost, N., Keilholz, U., Goerling, U.
Can routine register data be used to identify vulnerable lung cancer patients of suboptimal care in a German comprehensive cancer centre?
Han N, Heublein S, Jeschke U, Kuhn C, Hester A, Czogalla B, Mahner S, Rottmann M, Mayr D, Schmoeckel E, Trillsch F.
The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
Hossann, M., Hirschberger, J., Schmidt, R., Baumgartner, C., Zimmermann, K., Baer, S., Ratzlaff, C., Peller, M., Troedson, K., Limmer, S., Brühschwein, A., Dörfelt, R., Kreutzmann, N., Wess, G., Knösel, T., Schagon, O., Fischer, J., Grüll, H., Willerding, L., Schmidt, M., Meyer-Lindenberg, A., Issels, R.D., Schwaiger, M., Eggermont, A.M., ten Hagen, T.L. and Lindner, L.H. (2021)
A Heat-Activated Drug-Delivery Platform Based on Phosphatidyl-(oligo)-glycerol Nanocarrier for Effective Cancer Treatment
Issels, R. D., E. Noessner, L. H. Lindner, M. Schmidt, M. Albertsmeier, J. Y. Blay, E. Stutz, Y. Xu, V. Buecklein, A. Altendorf-Hofmann, S. Abdel-Rahman, U. Mansmann, M. von Bergwelt-Baildon, and T. Knoesel
Immune Infiltrates in Patients with Localised High-Risk Soft Tissue Sarcoma Treated with Neoadjuvant Chemotherapy without or with Regional Hyperthermia: A Translational Research Program of the Eortc 62961-Esho 95 Randomised Clinical Trial.
Jesinghaus, M., M. Schmitt, C. Lang, M. Reiser, A. Scheiter, B. Konukiewitz, K. Steiger, M. Sil-va, M. Tschurtschenthaler, S. Lange, S. Foersch, K. F. Becker, D. Saur, H. Friess, K. Halfter, J. Engel, M. Boxberg, N. Pfarr, D. Wilhelm, and W. Weichert
Morphology Matters: A Critical Reappraisal of the Clinical Relevance of Morphologic Criteria from the 2019 Who Classification in a Large Colorectal Cancer Cohort Comprising 1004 Cases.
Konukiewitz, B., M. Schmitt, M. Silva, J. Pohl, C. Lang, K. Steiger, K. Halfter, J. Engel, A. M. Schlitter, M. Boxberg, N. Pfarr, D. Wilhelm, S. Foersch, M. Tschurtschenthaler, W. Weichert, and M. Jesinghaus.
Loss of Cdx2 in Colorectal Cancer Is Associated with Histopathologic Subtypes and Microsatellite Instability but Is Prognostically Inferior to Hematoxylin-Eosin-Based Morphologic Parameters from the Who Classification.
Michl, M., F. Taverna, J. Kumbrink, T. S. Schiergens, V. Heinemann, J. Engel, T. Kirchner, and J. Neumann.
Biomarker Alterations Associated with Distinct Patterns of Metastatic Spread in Colorectal Cancer.
Scharl, S., C. Becher, M. Gerken, A. Scharl, M. Anapolski, A. Ignatov, E. C. Inwald, O. Ort-mann, O. Kölbl, M. Klinkhammer-Schalke, and T. Papathemelis
Is There a Benefit for Adju-vant Radio(Chemo)Therapy in Early Cervical Cancer? Results from a Population-Based Study
Scharl, S., M. Gerken, T. Sprötge, K. Kronberger, A. Scharl, A. Ignatov, O. Ortmann, O. Kölbl, M. Klinkhammer-Schalke, and T. Papathemelis
Comparison of Survival Outcomes and Ef-fects of Therapy between Subtypes of High-Grade Endometrial Cancer - a Population-Based Study
Scharl, S., T. Sprötge, M. Gerken, A. Scharl, A. Ignatov, E. C. Inwald, O. Ortmann, O. Kölbl, M. Klinkhammer-Schalke, and T. Papathemelis
Factors Influencing Treatment Decision and Guideline Conformity in High-Grade Endometrial Cancer Patients: A Population-Based Study
Schrodi S., Braun M., Andrulat A., Harbeck N., Mahner S., Kiechle M., Klein E., Schnelzer A., Schindlbeck C., Bauerfeind I., Schubert-Fritschle G., Nekljudova V., Mayr D., Weichert W., Denkert C., Loibl S., Engel J.Outcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohort
Spoerl, S., G. Spanier, E. Reiter, M. Gerken, S. Haferkamp, J. Grosse, K. Drexler, T. Ettl, M. Klinkhammer-Schalke, R. Fischer, S. Spoerl, T. E. Reichert, and C. Klingelhöffer
Head and Neck Melanoma: Outcome and Predictors in a Population-Based Cohort Study
Stangl S., Rauch S., Rauh J., Meyer M., Müller-Nordhorn J., Wildner M., Wöckel A., Heuschmann P.U.
Disparities in accessibility to evidence-based breast cancer care facilities by rural and urban areas in Bavaria, Germany.
Thurmaier, J., V. Heinemann, J. Engel, G. Schubert-Fritschle, M. Wiedemann, N. C. Nüssler, R. Ruppert, J. Kleeff, W. Schepp, F. Löhe, M. Karthaus, J. Neumann, J. Kumbrink, F. Taverna, A. Stahler, K. Heinrich, C. B. Westphalen, J. W. Holch, T. Kirchner, and M. Michl
Patients with Colorectal Cancer and Brain Metastasis: The Relevance of Extracranial Metastatic Pat-terns Predicting Time Intervals to First Occurrence of Intracranial Metastasis and Survival
Trillsch, F., S. Mahner, B. Czogalla, M. Rottmann, R. Chekerov, E. I. Braicu, G. Oskay-Öczelik, P. Wimberger, R. Richter, and J. Sehouli
Primary Platinum Resistance and Its Prognostic Im-pact in Patients with Recurrent Ovarian Cancer: An Analysis of Three Prospective Trials from the Noggo Study Group
Villegas, S. L., V. Nekljudova, N. Pfarr, J. Engel, M. Untch, S. Schrodi, F. Holms, H. U. Ulmer, P. A. Fasching, K. E. Weber, C. Albig, C. Heinrichs, F. Marmé, A. Hartmann, C. Hanusch, W. D. Schmitt, J. Huober, B. Lederer, M. van Mackelenbergh, H. Tesch, C. Jackisch, M. Rezai, P. Sinn, B. V. Sinn, J. Hackmann, M. Kiechle, A. Schneeweiss, W. Weichert, C. Denkert, and S. Loibl
Therapy Response and Prognosis of Patients with Early Breast Cancer with Low Positivity for Hormone Receptors - an Analysis of 2765 Patients from Neoadjuvant Clinical Trials
Voigtländer, S., A. Hakimhashemi, E. C. Inwald, O. Ortmann, M. Gerken, S. J. Klug, M. Klink-hammer-Schalke, M. Meyer, and J. Müller-Nordhorn
Auswirkungen Der Covid-19-Pandemie Auf Die Zahl Der Krebsneuerkrankungen Und Krebsbehandlungen Nach Tumorstadium in Bayern
Willvonseder, B., F. Stögbauer, K. Steiger, M. Jesinghaus, P. H. Kuhn, C. Brambs, J. Engel, H. Bronger, G. P. Schmidt, B. Haller, W. Weichert, G. Keller, A. Noske, N. Pfarr, and M. Boxberg
The Immunologic Tumor Microenvironment in Endometrioid Endometrial Cancer in the Mor-phomolecular Context: Mutual Correlations and Prognostic Impact Depending on Molecular Al-terations
2020
Albertsmeier, M., A. Altendorf-Hofmann, L. H. Lindner, R. D. Issels, E. Kampmann, H. R. Dürr, G. Schubert-Fritschle, M. K. Angele, T. Kirchner, A. A. Jungbluth, and T. Knösel
Cancer Testis Antigens and Immunotherapy: Expression of Prame Is Associated with Prognosis in Soft Tissue Sarcoma.
Albertsmeier, M., K. Riedl, A. J. Stephan, M. Drefs, T. S. Schiergens, J. Engel, M. K. Angele, J. Werner, and M. Guba
Improved Survival after Resection of Colorectal Liver Metastases in Patients with Unresectable Lung Metastases.
Bielska-Lasota, M., S. Rossi, M. Krzyzak, A. Haelens, A. Domenic, R. De Angelis, A. Maciejczyk, M. Rodriguez-Barranco, V. Zadnik, P. Minicozzi, and Eurocare- Working Group
Reasons for Low Cervical Cancer Survival in New Accession European Union Countries: A Eurocare-5 Study.
Czogalla, B., Pham, D., Trillsch, F., Rottmann, M., Gallwas, J., Burges, A., Mahner, S., Kirchner, T., Jeschke, U., Mayr, D. & Schmoeckel, E. (2020).
PD‑L1 expression and survival in p16‑negative and ‑positive squamous cell carcinomas of the vulva.
De Toni, E. N., A. Schlesinger-Raab, M. Fuchs, W. Schepp, U. Ehmer, F. Geisler, J. Ricke, P. Paprottka, H. Friess, J. Werner, A. L. Gerbes, J. Mayerle, and J. Engel
Age Independent Sur-vival Benefit for Patients with Hepatocellular Carcinoma (Hcc) without Metastases at Diagno-sis: A Population-Based Study.
Ditsch, N., Heublein, S., Jeschke, U., Sattler, C., Kuhn, C., Hester, A., Czogalla, B., Trillsch, F., Mahner, S., Engel, J., Mayr, D. & Schmoeckel, E. (2020).
Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients.
Finke, I., Behrens, G., Schwettmann, L., Gerken, M., Pritzkuleit, R., Holleczek, B., Brenner, H., Jansen, L., & German Cancer Survival Working Group.
Socioeconomic differences and lung cancer survival in Germany: Investigation based on population-based clinical cancer registration.
Gödde, K., Fügemann, H., Müller-Nordhorn, J., Grimberg, M., Goerling, U., Siegerink, B., Rieckmann, N., Holmberg, C.
Strukturierte Erfassung von Unterstützungsangeboten für Lungenkrebs- und Schlaganfallbetroffene in Berlin [Structured Collection of Data on Support Offers for Lung Cancer and Stroke Patients in Berlin].
Grundmann, N., Meisinger, C., Trepel, M., Müller-Nordhorn, J., Schenkirsch, G., Linseisen, J.
Trends in cancer incidence and survival in the Augsburg study region-results from the Augsburg cancer registry.
Han, N., Jeschke, U., Kuhn, C., Hester, A., Czogalla, B., Mahner, S., Rottmann, M., Mayr, D., Schmoeckel, E., & Trillsch, F.
H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology.
Jansen, L., Behrens, G., Finke, I., Maier, W., Gerken, M., Pritzkuleit, R., Holleczek, B., Brenner, H., & German Cancer Survival Working Group (May 2020).
Area-Based Socioeconomic Inequalities in Colorectal Cancer Survival in Germany: Investigation Based on Population-Based Clinical Cancer Registration.
Papathemelis, T., Oppermann, H., Grafl, S., Gerken, M., Pauer, A., Scharl, S., Scharl, A., Inwald, E., Ignatov, A., Ortmann, O., Klinkhammer-Schalke, M., Hein, A., Beckmann, M. W. & Lux, M. P. (2020).
Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. Open procedure.
Prantl, L., Gerken, M., Zeman, F., Leitzmann, M., Koller, M., Klinkhammer-Schalke, M., Evert, M., Kuehlmann, B. & Biermann, N (2020).
Incidence of Anaplastic Large Cell Lymphoma and Breast-Implant-Associated Lymphoma—An Analysis of a Certified Tumor Registry over 17 Years.
Schmuck, R., M. Gerken, E. M. Teegen, I. Krebs, M. Klinkhammer-Schalke, F. Aigner, J. Pratschke, B. Rau, and S. Benz
Gender Comparison of Clinical, Histopathological, Therapeu-tic and Outcome Factors in 185,967 Colon Cancer Patients
Schnitzbauer, V., M. Gerken, S. Benz, V. Völkel, T. Draeger, A. Fürst, and M. Klinkhammer-Schalke
Laparoscopic and Open Surgery in Rectal Cancer Patients in Germany: Short and Long-Term Results of a Large 10-Year Population-Based Cohort.
Schultze, M., Müller-Nordhorn, J., Holmberg, C.
Discussing the effects of prostate cancer beyond biographical disruption and new normalcy: the experiences of men with prostate cancer in Germany.
Spanier, G., Böttcher, J., Gerken, M., Fischer, R., Roth, G., Lehn, P., Klingelhöffer, C., Meier, J. K., Fraccaroli, A., Tischer, J., Ettl, T., Klinkhammer-Schalke, M., Reichert, T. E. & Spoerl, S.
Prognostic value of perioperative red blood cell transfusion and anemia on survival and recurrence in oral squamous cell carcinoma.
Spoerl, S., M. Gerken, R. Fischer, A. Mamilos, S. Spoerl, S. Wolf, F. Pohl, C. Klingelhöffer, T. Ettl, T. E. Reichert, and G. Spanier
Lymphatic and Vascular Invasion in Oral Squamous Cell Carcinoma: Implications for Recurrence and Survival in a Population-Based Cohort Study
Spoerl, S., Gerken, M., Mamilos, A., Fischer, R., Wolf, S., Nieberle, F., Klingelhöffer, C., Meier, J. K., Spoerl, S., Ettl, T., Reichert, T. E. & Spanier, G. (2020).
Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.
Stangl, S., K. Haas, F. A. Eichner, A. Grau, U. Selig, T. Ludwig, T. Fehm, T. Stüber, A. Rashid, A. Kerscher, R. Bargou, S. Hermann, V. Arndt, M. Meyer, M. Wildner, H. Faller, M. G. Schrau-der, M. Weigel, U. Schlembach, P. U. Heuschmann, and A. Wöckel
Development and Proof-of-Concept of a Multicenter, Patient-Centered Cancer Registry for Breast Cancer Patients with Metastatic Disease-the "Breast Cancer Care for Patients with Metastatic Disease" (Bre-4-Med) Registry
Taubenhansl, C., Ortmann, O., Gerken, M., Inwald, E.C. und Klinkhammer-Schalke, M.
Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients.
Teufel A, Gerken M, Fürst A, Ebert M, Hohenthanner I, Klinkhammer-Schalke M.
Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer.
Trillsch, F., Mahner, S., Czogalla, B., Rottmann, M., Chekerov, R., Braicu, E. I., Oskay-Öczelik, G., Wimberger, P., Richter, R. & Sehouli, J.
Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group.
2019
Bösch, F., K. Brüwer, A. Altendorf-Hofmann, C. J. Auernhammer, C. Spitzweg, C. B. Westpha-len, S. Boeck, G. Schubert-Fritschle, J. Werner, V. Heinemann, T. Kirchner, M. Angele, and T. Knösel
Immune Checkpoint Markers in Gastroenteropancreatic Neuroendocrine Neoplasia.
Draeger, T., V. Völkel, V. Schnitzbauer, M. Gerken, S. Benz, M. Klinkhammer-Schalke, and A. Fürst.
Laparoscopic and Open Resection of Rectal Cancer-Is Age an Effect Modifier for Short- and Long-Term Survival?
Elmasry, M., L. Brandl, J. Engel, A. Jung, T. Kirchner, and D. Horst.
Rbp7 Is a Clinically Prog-nostic Biomarker and Linked to Tumor Invasion and Emt in Colon Cancer.
Gatta, G., A. Trama, R. Capocaccia, and R. ARECARENet Working Group.
Epidemiology of Rare Cancers and Inequalities in Oncologic Outcomes.
Imbimbo, M., J. M. Maury, M. Garassino, N. Girard, and R. ARECAREnet Working Group.
Mesothelioma and Thymic Tumors: Treatment Challenges in (Outside) a Network Setting.
Lauseker, M., K. Bachl, A. Turkina, E. Faber, W. Prejzner, U. Olsson-Strömberg, M. Baccarani, E. Lomaia, D. Zackova, G. Ossenkoppele, L. Griskevicius, G. Schubert-Fritschle, T. Sacha, S. Heibl, P. Koskenvesa, A. Bogdanovic, R. E. Clark, J. Guilhot, V. S. Hoffmann, J. Hasford, A. Hochhaus, and M. Pfirrmann
Prognosis of Patients with Chronic Myeloid Leukemia Present-ing in Advanced Phase Is Defined Mainly by Blast Count, but Also by Age, Chromosomal Aber-rations and Hemoglobin.
Lykoudis, P. M., S. Partelli, F. Muffatti, M. Caplin, M. Falconi, G. K. Fusai, and R. ARECARENet Working Group.
Treatment Challenges in and Outside a Specialist Network Setting: Pancreatic Neuroendocrine Tumours.
Nicolai, N., D. Biasoni, M. A. Catanzaro, M. Colecchia, A. Trama, and R. ARECAREnet Work-ing Group.
Testicular Germ-Cell Tumours and Penile Squamous Cell Carcinoma: Appropriate Management Makes the Difference.
Orlandi, E., S. Alfieri, C. Simon, A. Trama, L. Licitra, and R. ARECAREnet Working Group.
Treatment Challenges in and Outside a Network Setting: Head and Neck Cancers.
Papathemelis, T., S. Knobloch, M. Gerken, A. Scharl, M. Anapolski, A. Ignatov, E. C. Inwald, O. Ortmann, S. Scharl, and M. Klinkhammer-Schalke
Impact of Nodal Status and Treatment Strategy on Overall Survival in Advanced Stage Cervical Cancer.
Pasquali, S., S. Bonvalot, D. Tzanis, P. G. Casali, A. Trama, A. Gronchi, and R. ARECARENet Working Group
Treatment Challenges in and Outside a Network Setting: Soft Tissue Sarcomas.
Pölcher, M., Rottmann, M., Brugger, S., Mahner, S., Dannecker, C., Kiechle, M., Brambs, C., Grab, D., Anthuber, C., von Koch, F., Schnelzer, A. & Engel, J. (2019).
Lymph node dissection in endometrial cancer and clinical outcome: A population-based study in 5546 patients.
Radespiel-Tröger, M., Voigtländer, S., Meyer, M., Müller-Nordhorn, J., Behringer, J., Schöfl, C., & Hollederer, A. (2019).
Assoziation zwischen Häufigkeit der Sonographie und Prävalenz bösartiger Neubildungen der Schilddrüse bei Versicherten der AOK in Bayern.
Ray-Coquard, I., A. Trama, M. J. Seckl, C. Fotopoulou, P. Pautier, S. Pignata, G. Kristensen, G. Mangili, H. Falconer, L. Massuger, J. Sehouli, E. Pujade-Lauraine, D. Lorusso, F. Amant, E. Rokkones, I. Vergote, J. A. Ledermann, and R. ARECARENet Working Group
Rare Ovarian Tumours: Epidemiology, Treatment Challenges in and Outside a Network Setting
Schmoeckel, E., Hofmann, S., Fromberger, D., Rottmann, M., Luthardt, B., Burges, A., Jeschke, U., Kirchner, T., Lax, S. F. & Mayr, D. (2019).
Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic facors in ovarian carcinoma.
Völkel V, Draeger T, Schnitzbauer V, Gerken M, Benz S, Klinkhammer-Schalke M, Fürst A.
Surgical treatment of rectal cancer patients aged 80 years and older-a German nationwide analysis comparing short- and long-term survival after laparoscopic and open tumor resection.
Wimmer T, Ortmann O, Gerken M, Klinkhammer-Schalke M, Koelbl O, Inwald EC.
Adherence to guidelines and benefit of adjuvant radiotherapy in patients with invasive breast cancer: results from a large population-based cohort study of a cancer registry.
2018
Blödt S, Kaiser M, Adam Y, Adami S, Schultze M, Müller-Nordhorn J, Holmberg C.
Understanding the role of health information in patients’ experiences: secondary analysis of qualitative narrative interviews with people diagnosed with cancer in Germany.
Corradini, S., Pazos, M., Schönecker, S., Reitz, D., Niyazi, M., Ganswindt, U., Schrodi, S., Braun, M., Pölcher, M., Mahner, S., Harbeck, N., Engel, J. & Belka, C. (2018).
Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases.
Heckl, M., Schmoeckel, E., Hertlein, L., Rottmann, M., Jeschke, U. & Mayr, D. (2018).
The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
Weiss, M., Sim, D. A., Herold, T., Schumann, R. G., Liegl, R., Kern, C., Kreutzer, T., Schiefelbein, J., Rottmann, M., Priglinger, S. & Kortuem, K. U. (2018).
Compliance and Adherence of Patients with Diabetic Macular Edema to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Daily Practice.
Würstlein, R., Hesse, A., König, A., Schulte-Vorwick, F., Schrodi, S., Ditsch, N., Mahner, S. & Harbeck, N. (2018).
Tastbefund an der Brust: Auch bei Männern immer abklären!
2017
Bastiaannet, E., Charman, J., Johannesen, T. B., Schrodi, S., Siesling, S., van Eycken, L., Walsh, P. M., Audisio, R. A., Boelens, P. G., Rubio, I. T., Jones, N., Lewis, J. & van de Velde, C. J. H.
A European, Observational Study of Endocrine Therapy Administration in Patients with an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer.
Engler J, Güthlin C, Dahlhaus A, Kojima E, Müller-Nordhorn J, Weißbach L, Holmberg C.
Physician cooperation in outpatient cancer care. An amplified secondary analysis of qualitative interview data.
Giesler JM, Keller B, Repke T, Leonhart R, Weis J, Muckelbauer R, Rieckmann N, Müller-Nordhorn J, Lucius-Hoene G, Holmberg C.
Effect of a Website That Presents Patients‘ Experiences on Self-Efficacy and Patient Competence of Colorectal Cancer Patients: Web-Based Randomized Controlled Trial.
Rottmann, M., Burges, A., Mahner, S., Anthuber, C., Beck, T., Grab, D., Schnelzer, A., Kiechle, M., Mayr, D., Pölcher, M., Schubert-Fritschle, G., & Engel J. (2017).
Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes.
Schmoeckel, E., Odai-Afotey, A. A., Schleißheimer, M., Rottmann, M., Flesken-Nikitin, A., Ellenson, L. H., Kirchner, T., Mayr, D. & Nikitin, A. Y. (2017).
LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions.
Twardella, D., Geiss, K., Radespiel-Tröger, M., Benner, A., Ficker, J.H., & Meyer, M.
Trends der Lungenkrebsinzidenz nach histologischem Subtyp bei Männern und Frauen in Deutschland. Analyse von Krebsregisterdaten unter Einsatz von multipler Imputation.
2016
Engler J, Adami S, Adam Y, Keller B, Repke T, Fügemann H, Lucius-Hoene G, Müller-Nordhorn J, Holmberg C. (2016).
Using others‘ experiences. Cancer patients’ expectations and navigation of a website providing narratives on prostate, breast and colorectal cancer.
2015
Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Stabenow R, Froehner M, Huber J
Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer:
A comparison of treatment trends in the United States and Germany from 2004 to 2011
Keller AK, Uter W, Pfahlberg AB, Radespiel-Tröger M, Mayer I, Gefeller O.
Replacing surrogate measures by direct quantification of ultraviolet radiation exposure
in registry-based analyses of seasonality of melanoma diagnoses.
2014
Nennecke A, Geiss K, Hentschel S, Vettorazzi E, Jansen L, Eberle A, Holleczek B, Gondos A, Brenner H,
and the GEKID cancer survival working group
Survival of cancer patients in urban and rural areas of Germany - a comparison.
Radespiel-Tröger M, Batzler WU, Holleczek B, Luttmann S, Pritzkuleit R, Stabenow R, Urbschat I, Zeissig SR, Meyer M.
Im Namen der Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (GEKID)
Inzidenzzunahme des papillären Schilddrüsenkarzinoms in Deutschland
2013
Geiss K, Meyer M.
A Windows application for computing standardized mortality ratios and
standardized incidence ratios in cohort studies based on calculation of exact person-years at risk
Schrodi S, Braisch U, Schenkirsch G, Maisel T, Petsch S, Hölzel D, Klinkhammer-Schalke M,
Mäder U, Schuller L, Heywang-Köbrunner SH, Meyer M, Engel J.
Veränderungen der Therapie des Mammakarzinoms in Bayern seit Einführung des Mammografie-Screenings.
Eine Analyse bayerischer Krebsregisterdaten der Jahre 2000 bis 2008
2012
Braisch U, Geiss K, Radespiel-Tröger M, Meyer M.
Population-Based Effects of Mammography Screening in Bavaria on the Distribution of TNM-T Categories
with Respect to Different Histological Subgroups
Braisch U, Meyer M, Radespiel-Tröger M.
Risk of subsequent primary cancer among prostate cancer patients in Bavaria, Germany.
Braisch U, Meyer M, Radespiel-Tröger M
Risk of tobacco-related multiple primary cancers in Bavaria, Germany
Kuznetsov L, Maier W, Hunger M, Meyer M, Mielck A.
Regional deprivation in Bavaria, Germany:
linking a new deprivation score with registry data for lung and colorectal cancer .
Nennecke A, Barnes B, Brenner H, Eberle A, Emrich K, Eisemann N, Geiss K, Hentschel S, Holleczek B, Kraywinkel K, Stabenow R, Hense HW.
Datenqualität oder Unterschiede in der onkologischen Versorgung?
- Berichtsstandards für Überlebenszeitanalysen mit Krebsregisterdaten
Radespiel-Tröger M, Meyer M.
Association between drinking water uranium content and cancer risk in Bavaria, Germany
Radespiel-Tröger M, Meyer M, Fenner M.
Geographic differences and time trends of intraoral cancer incidence and mortality in Bavaria, Germany.
2011
Kuznetsov L, Maier W, Hunger M, Meyer M, Mielck A.
Associations between regional socioeconomic deprivation and cancer risk:
Analysis of population-based Cancer Registry data from Bavaria, Germany.
Radespiel-Tröger, M.
Radespiel-Tröger M:
2010
Katalinic A, Emrich K,Luttmann S, Holleczek B, Stabenow R, Urbschat I, Meyer M:
Nennecke A, Brenner H, Eberle A, Geiss K, Holleczek B, Kieschke J, Kraywinkel K,
GEKID-Arbeitsgruppe "Überlebenszeitanalyse":
Überlebenschancen von Krebspatienten in Deutschland - auf dem Weg zu repräsentativen, vergleichbaren Aussagen
2009
Geiss K, Meyer M, Radespiel-Tröger M, Gefeller O.:
SURVSOFT-Software for nonparametric survival analysis.
Meyer M, Opitz T, Caselmann WH, Schenkirsch G, Maisel T, Petsch S, Engel J,
Radespiel-Tröger M, Meyer M, Pfahlberg A, Lausen B, Gefeller O:
Outdoor work and skin cancer incidence: a registry based study in Bavaria.
Staykov D, Radespiel-Tröger M, Meyer M, Petsch S, Schwab S and Handschu R:
Birth Month and Risk of Glioma in Adults: A Registry-Based Study in Bavaria.
2008
2006
Meyer M, Gärtig-Daugs A, Radespiel-Tröger M:
Mobilfunkbasisstationen und Krebshäufigkeit in Bayern
Meyer M, Gärtig-Daugs A, Radespiel-Tröger M:
Vorträge und Poster
2021
Qualitätskonferenz des Bayerischen Krebsregisters
2011
Geiss K, Braisch U, Schrodi S, Schenkirsch G, Maisel T, Petsch S, Klinkhammer-Schalke M, Mäder U, Hölzel D, Heywang-Köbrunner, Engel J, Meyer M
Meyer M:
Automatisches Best-of - Datenbankimplementierung des Lokalisationsbaums .Vortrag
bei der 19. Informationstagung Tumordokumentation der klinischen und epidemiologischen Krebsregister,
Bayreuth, 30.3.2011
2005
Meyer M, Gärtig-Daugs A, Radespiel-Tröger M:Krebsinzidenz im Umkreis von Mobilfunkbasisstationen (PDF-Datei 300 kB)
2004
Daugs A:
Epidemiologische Grundbegriffe (PDF-Datei 215 kB)
Gärtig-Daugs A, Radespiel-Tröger M, Meyer M:
Simulationsmodell zur Unterstützung der Risikokommunikation in der Krebsepidemiologie (PDF-Datei 794 kB)
Meyer M, Radespiel-Tröger M, Petsch S, Schick S, Friedrich M:
Epidemiologische Krebsregistrierung: Maßnahmen zur Erreichung einer hohen Datenqualität (PDF-Datei 570 kB)
Radespiel-Tröger M, Daugs A, Meyer M:
Simulation model for visualisation of small-area cancer incidence rates (PDF-Datei 1013 kB)
2003
2000
